Highly active antiretroviral therapy

The Annals of Pharmacotherapy, 2001
OBJECTIVE: To report four cases of HIV-associated gynecomastia diagnosed during treatment with nucleoside analogs with or without protease inhibitors. CASE SUMMARY: Four HIV-infected patients developed gynecomastia while taking two nucleoside analogs (stavudine combined with lamivudine in 3 patients, stavudine with didanosine in 1 patient) and protease
R, Manfredi, L, Calza, F, Chiodo
openaire +2 more sources

Highly Active Antiretroviral Therapy-Induced Liver Injury

Current Drug Safety, 2008
With the advent of highly active antiretroviral therapy (HAART), the reduction in overall mortality and morbidity in HIV patients has been accompanied by the emergence of liver disease as a leading cause of death. Elevated liver enzymes may be due to HAART or to other risk factors, including hepatitis co-infection and alcohol use.
Ira, Inductivo-Yu, Maurizio, Bonacini
openaire +2 more sources

HIV transmission under highly active antiretroviral therapy

The Lancet, 2008
1806 www.thelancet.com Vol 372 November 22, 2008 iveness of treat ment in reducing the risk of HIV trans mission per sexual act was about the same as has been report ed for condoms.” There fore, even with their high esti mates, Wilson and colleagues con fi rm the Swiss statement and even docu ment a higher risk for condom use (with out treatment) than ...
Vernazza, Pietro +3 more
openaire +3 more sources

medicine
antiretroviral therapy
human immunodeficiency virus hiv

viral load
internal medicine
immunology

humans
3. good health
antiretroviral therapy, highly active